Seroprevalence of hepatitis C in patients with type 2 diabetes mellitus and non-diabetic on haemodialysis

International Journal of Clinical Practice

Volumn 60, Issue 6, 2006, Pages 670-674

  Ocak, Sabahattin ^a   Duran, N ^a   Kaya, H ^a   Emir, I ^b  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b Antakya Emir Haemodialysis Center   (Turkey)

Author keywords

Antibody; Diabetes mellitus; ELISA; Haemodialysis; HCV

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; SEROPREVALENCE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TURKEY;

EID: 33744517113     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2006.00738.x     Document Type: Article

References (30)

1. Tokars JI, Miller ER, Alter MJ et al. National surveillance of dialysis associated diseases in the United States, 1995. ASAIO J 1998; 44: 98-107.
2. Malaponte G, Bevelacqua V, Fatuzzo P et al. IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age. Nephrol Dial Transplant 2002; 17: 1964-70.
3. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002; 36 (5 Suppl 1): S74-83.
4. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.
5. Fakunle YM, Al-Moffareh M, El-Karamany WM et al. Prevalence of antibodies to hepatitis C virus in haemodialysis patients in Riyadh. Ann Saudi Med 1991; 11: 504-6.
6. McIntyre PG, McCruden EA, Dow BC et al. Hepatitis C virus infection in renal dialysis patients in Glasgow. Nephrol Dial Transplant 1994; 9: 291-5.
7. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
8. Mason AL, Lau JY, Hoang N et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328-33.
9. Soma J, Saito T, Taguma Y et al. High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy. J Am Soc Nephrol 2000; 11: 690-9.
10. Knobler H, Schihmanter R, Zifroni A et al. Increased risk of type-2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 2000; 75: 355-9.
11. Mehta SH, Brancati FL, Sulkowski MS et al. Prevalence of type-2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-9.
12. Caronia S, Taylor K, Pagliaro L et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059-63.
13. Mangia A, Schiavone G, Lezzi G et al. HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol 1998; 93: 2363-7.
14. Sotiropoulos A, Peppas TA, Skliros E et al. Low prevalence of hepatitis C virus infection in Greek diabetic patients. Diabet Med 1999; 16: 250-2.
15. Saxena AK, Panhotra BR. The susceptibility of patients with type-2 diabetes to hepatitis C virus infection during long-term haemodialysis. Swiss Med Wkly 2003; 133: 611-8.
16. Fabrizi F, Lampertico P, Lunghi G et al. Review article hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation. Aliment Pharmacol Ther 2005; 21: 623-32.
17. Murthy BV, Pereira BJ. A 1990s percpective of hepatitis C, human immunodeficiency virus, and tuberculosis infections in dialysis patients. Semin Nephrol 1997; 17: 346-63.
18. Pujol FH, Ponce JG, Lema MG et al. High incidence of hepatitis C virus infection in haemodialysis patients in units with high prevalence. J Clin Microbiol 1996; 34: 1633-6.
19. Carneiro MA, Martins RM, Teles SA et al. Hepatitis C prevalence and risk factors in haemodialysis patients in Central Brazil: A survey by polymerase chain reaction and serological methods. Mem Inst Oswaldo Cruz 2001; 96: 765-9.
20. Carrera F, Silva JG, Oliveira C et al. Persistence of antibodies to hepatitis C virus in a chronic haemodialysis population. Nephron 1994; 68: 38-40.
21. al Nasser MN, al Mugeiren MA, Assuhaimi SA et al. Seropositivity to hepatitis C virus in Saudi haemodialysis patients. Vox Sang 1992; 62: 94-7.
22. Simo R, Hernandez C, Genesca J et al. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996; 19: 998-1000.
23. Salmela PI, Sotaniemi EA, Nemi N et al. Liver function tests in diabetic patients. Diabetes Care 1984; 7: 248-54.
24. Thuluvath PJ, John PR. Association between hepatitis C, diabetes mellitus, and race: A case-control study. Am J Gastroenterol 2003; 98: 438-41.
25. Arao M, Murase K, Kusakabe A et al. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J Gastroenterol 2003; 38: 355-60.
26. Yang SQ, Chen HS, Jiang D et al. Relationship between chronic hepatitis C and type II diabetes mellitus. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2003; 17: 46-9.
27. el-Zayadi AR, Selim OE, Hamdy H et al. Association of chronic hepatitis C infection and diabetes mellitus. Trop Gastroenterol 1998; 19: 141-4.
28. Ryu JK, Lee SB, Hong SJ et al. Association of chronic hepatitis C virus infection and diabetes mellitus in Korean patients. Korean J Intern Med 2001; 16: 18-23.
29. Rudoni S, Petit JM, Bour JB et al. HCV infection and diabetes mellitus: influence of the use of finger stick devices on nosocomial transmission. Diabetes Metab 1999; 25: 502-5.
30. Okan V, Araz M, Aktaran S et al. Increased frequency of HCV but not HBV infection in type-2 diabetic patients in Turkey. Int J Clin Pract 2002; 56: 175-7.